BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21052504)

  • 1. Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction.
    Cha DS; Lee H; Park MS; Lee JM; Baek SH
    Korean J Ophthalmol; 2010 Oct; 24(5):261-6. PubMed ID: 21052504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan.
    Hung CH; Chen YC; Lin SL; Chen WL
    Pediatr Neonatol; 2015 Dec; 56(6):402-7. PubMed ID: 26026949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasolacrimal duct office probing in children under the age of 12 months: Cure rate and cost evaluation.
    Le Garrec J; Abadie-Koebele C; Parienti JJ; Molgat Y; Degoumois A; Mouriaux F
    J Fr Ophtalmol; 2016 Feb; 39(2):171-7. PubMed ID: 26826746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Endoscopically Assisted Primary Probing and Bicanalicular Silicone Intubation for Congenital Nasolacrimal Duct Obstruction in Children Aged 4 to 7 Years.
    Arici C; Mergen B; Ozan T; Batu Oto B
    J Pediatr Ophthalmol Strabismus; 2023; 60(2):101-107. PubMed ID: 35446188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success.
    Kashkouli MB; Kassaee A; Tabatabaee Z
    J AAPOS; 2002 Dec; 6(6):360-3. PubMed ID: 12506276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence and recurrence of tympanostomy tube procedures in children who underwent nasolacrimal duct probe and intubation for congenital nasolacrimal duct obstruction.
    Vicinanzo MG; Cooper KM; Gerber AL; Long J; McGwin G
    J AAPOS; 2023 Oct; 27(5):286.e1-286.e4. PubMed ID: 37734706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal endoscopy-guided primary nasolacrimal duct intubation for congenital nasolacrimal duct obstruction in children older than 4 years.
    Arici C; Oto BB
    Int Ophthalmol; 2023 Mar; 43(3):1005-1011. PubMed ID: 36053476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Success rates of probing for congenital nasolacrimal duct obstruction at various ages.
    Świerczyńska M; Tobiczyk E; Rodak P; Barchanowska D; Filipek E
    BMC Ophthalmol; 2020 Oct; 20(1):403. PubMed ID: 33032542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age on primary balloon dacryocystoplasty and probing success in congenital nasolacrimal duct obstruction.
    Dericioğlu V; Sevik MO; Saçu SS; Eraslan M; Çerman E
    Int Ophthalmol; 2022 Nov; 42(11):3547-3554. PubMed ID: 35598226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Success Rate of Probing for Congenital Nasolacrimal Duct Obstruction in Children.
    Valcheva KP; Murgova SV; Krivoshiiska EK
    Folia Med (Plovdiv); 2019 Mar; 61(1):97-103. PubMed ID: 31237856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital nasolacrimal duct obstruction update study (CUP study): Paper II - Profile and outcomes of complex CNLDO and masquerades.
    Bansal O; Bothra N; Sharma A; Ali MJ
    Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110407. PubMed ID: 33068946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of lacrimal obstruction type on the efficacy of probing for congenital nasolacrimal duct obstruction].
    Zhao W; Chen LL; Xiang DM
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(35):2477-80. PubMed ID: 23158713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of balloon dacryocystoplasty to probing as the primary treatment of congenital nasolacrimal duct obstruction.
    Gunton KB; Chung CW; Schnall BM; Prieto D; Wexler A; Koller HP
    J AAPOS; 2001 Jun; 5(3):139-42. PubMed ID: 11404738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.
    Mannor GE; Rose GE; Frimpong-Ansah K; Ezra E
    Am J Ophthalmol; 1999 May; 127(5):616-7. PubMed ID: 10334364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pushed monocanalicular intubation versus probing for the treatment of simple and incomplete complex types of congenital nasolacrimal duct obstruction in children older than 18 months old.
    Eshraghi B; Khalilipour E; Ameli K; Bazvand F; Mirmohammadsadeghi A
    Orbit; 2017 Aug; 36(4):218-222. PubMed ID: 28627958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Probing in Congenital Nasolacrimal Duct Obstruction in Children Older Than 2 Years.
    Une VL; Kulkarni SS; Nandedkar VS
    J Pediatr Ophthalmol Strabismus; 2019 May; 56(3):141-145. PubMed ID: 31116859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of amblyogenic factors in children with persistent congenital nasolacrimal duct obstruction.
    Eshraghi B; Akbari MR; Fard MA; Shahsanaei A; Assari R; Mirmohammadsadeghi A
    Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1847-52. PubMed ID: 24777709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing for congenital nasolacrimal duct obstruction in older children.
    Eshragi B; Fard MA; Masomian B; Akbari M
    Middle East Afr J Ophthalmol; 2013; 20(4):349-52. PubMed ID: 24339688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Success rates of dacryoendoscopy-guided probing for recalcitrant congenital nasolacrimal duct obstruction.
    Fujimoto M; Ogino K; Matsuyama H; Miyazaki C
    Jpn J Ophthalmol; 2016 Jul; 60(4):274-9. PubMed ID: 27116947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital Nasolacrimal Duct Obstruction: Comparison of Two Different Treatment Algorithms.
    Napier ML; Armstrong DJ; McLoone SF; McLoone EM
    J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):285-91. PubMed ID: 27486727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.